Active ingredientsIDENTITY AND SPECIFICATIONS

Regorafenib

Regorafenib is a small-molecule pharmaceutical ingredient classified as a multikinase inhibitor. This page concerns ingredient identity and technical-document enquiries; commercial specifications must be checked against official product documents.

CHEMICAL IDENTITY

Ingredient identity

International name
Regorafenib
CAS Registry Number
755037-03-7
Identity basis
Parent compound; commercial form to be confirmed
Therapeutic category
Oncology

The displayed CAS identifies the parent compound. It does not establish the salt, hydrate, polymorph, purity or grade of the material supplied by Baran. Confirm the actual form and corresponding CAS against its official CoA and specification.

PubChem: Regorafenib (CID 11167602) ↗

Documents for technical evaluation

Before evaluating or ordering an ingredient, request the exact chemical form, quality specification, test methods, storage conditions and packaging information. A certificate of analysis should correspond to the actual batch and agreed specification.

This page concerns the raw pharmaceutical ingredient. It does not provide finished-medicine administration information.